What the pitch says: “Get to $10M of EBITDA and you’ll trade at 8× instead of 4×. You’re not just adding earnings. You’re doubling the price of every dollar you already had.”
What’s actually true: the multiple does expand with size, but not because the number on the EBITDA line got bigger. It expands because the thing a buyer is buying changes character as it grows. Miss that distinction and you can assemble a bigger company that trades at the same small-company multiple, or worse.
The arithmetic, stated fairly
Start with the version that’s real. A $2M-EBITDA services company might trade around 4×, call it $8M of enterprise value. Buy three similar competitors and integrate them into a $7–8M-EBITDA platform, and buyers stop pricing you as a small business. Platforms in that range routinely trade at 7–9×. Run it through:
- Before: $2M × 4 = $8M
- After (naive): $8M × 8 = $64M
But look at where that value actually comes from. Buying three similar companies at 4× costs roughly $24M. So of the $64M you end up holding, $8M was your original business and $24M was purchase price, leaving about $32M of value created.
Now price the re-rating on its own: $8M of combined EBITDA, repriced by four turns (4× to 8×), is worth $32M.
Those are the same number. Essentially none of the value created comes from owning more EBITDA, all of it comes from the multiple. The earnings you bought were, in cash terms, roughly a wash; you paid 4× and they’re still 4× worth of earnings. What you actually manufactured was a re-rating, applied across the whole combined business including the $2M you already owned.
That’s multiple arbitrage, and it’s a genuine value-creation engine. Private equity has run this playbook for forty years for a reason. It also tells you exactly where the risk sits: if the combined entity doesn’t earn the higher multiple, there is no gain to speak of. You have simply bought three companies at fair value and taken on the debt to do it.
What the multiple is actually paying for
Here’s the part the deck compresses. A buyer does not pay 8× for “bigger.” A buyer pays 8× for lower risk per dollar of earnings. Size is a proxy for that, not the cause. The things that actually earn the higher multiple:
- Customer diversification. A $2M company often has one client at 30% of revenue. Lose it and the earnings halve. A platform with the same client at 4% of revenue has genuinely de-risked, and that shows up in the multiple directly.
- Management depth. If the company still runs on the founder, a buyer is buying a job, not an asset. Platforms that survive the founder’s exit trade higher because the earnings survive too.
- Systems and reporting. Monthly financials that close in five days, a real ERP, defensible KPIs. Diligenceable earnings are worth more than earnings a buyer has to take on faith.
- Revenue quality. Recurring or contracted revenue trades above project or transactional revenue at any size.
Bolt-ons that improve these attributes earn the re-rate. Bolt-ons that just pile more revenue onto the same fragile base add EBITDA without adding multiple, and sometimes subtract it, because you’ve added integration risk without reducing operating risk.
Where the math quietly breaks
Three places, in order of how often they kill the return:
You paid up for the bolt-ons. If your platform trades at 8× but you’re buying $1M-EBITDA competitors at 5–6×, you’re creating value on the spread. If a competitive process pushes those tuck-ins to 7×, the arbitrage nearly vanishes and you’re taking on integration risk for almost no re-rating benefit. The entry multiple on the bolt-on is the whole game. Discipline there matters more than deal volume.
You added EBITDA but not diligenceable EBITDA. A quality-of-earnings firm will re-derive the combined number from bank statements and ledgers, and it will haircut every addback that doesn’t survive scrutiny, every dollar of revenue that isn’t clean, every “pro forma synergy” that hasn’t actually happened yet. The multiple applies to that number, not your model’s number.
You financed the roll-up in a way that eats the arbitrage. Multiple expansion is an equity-value story. If each acquisition stacked expensive leverage, the enterprise value can climb while equity value stalls, you re-rated the company and handed the gain to lenders. Leverage stacking in serial acquisitions is its own failure mode, and it’s the one first-time acquirers model least.
The timing tax nobody prices
There’s a fourth leak that’s really an execution problem: the best-priced bolt-ons, the motivated seller, the retirement, the partner dispute, go to the buyer who can close fast. If your capital structure can only move at senior-committee speed, you systematically lose the cheapest targets and win the expensive, fully-marketed ones. The acquirers who actually capture the arbitrage keep gap capital as a standing capability, so a 5.5× target doesn’t drift to 7× while the field exam gets scheduled. (We wrote about that gap in detail in “The Two Weeks That Kill Acquisitions”.)
Run your own file first
Before you assume the re-rate, it’s worth knowing how a credit team would read your company today, as a platform buyers would pay up for, or as a founder-dependent small business with good numbers. If you want that read straight, run the assessment or send us your documents.
Educational only. Nothing here is an offer of credit, a commitment to lend, or advice on any specific transaction. Illustrative multiples are directional, not a valuation.